Urological Disorders Resource Center
Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Patient Information Fact Sheets
Download or print easy-to-read disease leaflets for your patients.
Shire announced the launch of Natpara (parathyroid hormone) for injection indicated as adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism
For patients with prostate cancer, androgen deprivation therapy (ADT) could have a lasting impact on physical function.
Observational studies strongly support that there is a correlation between the two
The Food and Drug Administration (FDA) has approved a label update for Zytiga (abiraterone acetate; Janssen Biotech) to include statistically significant results in combination with prednisone for the treatment of chemotherapy-naive men with metastatic castration-resistant prostate cancer (mCRPC).
New statistics suggest that kidney patients on dialysis are surviving longer thanks to better treatments and tighter disease management.
In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.
Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.
Prostate cancer is the most common male-related malignancy in the US, the second most common cause of cancer-related death among men.
Featured courses from mycme
Among the many issues clinicians face today, staying current with advances in medicine is becoming ...
This module reviews all topics on the NCCPA examination blueprint relating to the Reproductive, Genitourinary, ...
With acute kidney injury often encountered in the outpatient setting, primary-care providers should know the ...